Immunoclassification of Psoriasis: a Strategy for Precision Medicine

Recruiting now · Not applicable

Conditions studied: Immunoclassification, Psoriasis

In brief

Through the combination of clinical manifestations and omics, the investigators aim to explore the skin cell atlas in different stages of psoriasis lesions, establish a clinical classification standard for psoriasis, and guide the precise treatment of psoriasis.

Key facts

Study ID

NCT05503875

Run by

Second Affiliated Hospital, Zhejiang University, School of Medicine

People needed

100

Starts

2023-01-01

Expected to finish

2027-12-31

Last updated by the study team

2024-01-12

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• 18 to 75 years of age 2.Moderate to severe chronic psoriasis, BSA≥3% 3.Duration of psoriasis≥6 months 4.Patients must be candidate for systemic therapy 5.Informed consent must be obtained 6.For female, ß-hCG test is negative and contraception is accepted

You may not qualify if…

• Having severe infections, including hepatitis, HIV and tuberculosis
• Having significant allergies to biological agents
• Having a history of malignancy
• Refusal of contraception
• Having serious or unstable/uncontrolled illnesses

Where it is running

• 2nd Affiliated Hospital, School of Medicine, Zhejiang University — Hangzhou, Zhejiang, China (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.